Alexandria Braun
Contatto Relazioni con gli Investitori presso ACUMEN PHARMACEUTICALS, INC.
Provenienza dei contatti di primo grado di Alexandria Braun
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 21 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Alexandria Braun tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer General Counsel Chief Tech/Sci/R&D Officer | |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | General Counsel Portfolio Manager-Equities | |
| Octagon Partners LLC | Corporate Officer/Principal | ||
Biosortia Pharmaceuticals, Inc.
 Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Biosortia Pharmaceuticals, Inc. engages as a researching and developing algal technology company. It focuses on commercialization of concentration, dewatering, drying, and extraction of biomass. The company was founded by Ross O. Youngs in 2008 and is headquartered in Columbus, OH. | Biotechnology | Director/Board Member | |
| ABBVIE INC. | Pharmaceuticals: Major | Sales & Marketing | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
NeuroVentures Capital LLC
 NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital LLC (NeuroVenture Capital) is a venture capital firm founded in 1999 by Mark A. Cochran, Daniel J. O'Connell and Hans von Celsing. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Founder | |
| Indiana University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Doctorate Degree | |
| University of Cincinnati (Ohio) | College/University | Undergraduate Degree | |
| University of Delaware | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| Georgetown University | College/University | Doctorate Degree | |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member | |
PBM Products LLC
 PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables PBM Products LLC entered into an exclusive supply arrangement to introduce the first private-label (store-brand) infant formulas in the United States. Today store-brand infant formulas have become increasingly important to retailers, and an affiliate company, PBM Nutritionals LLC manufactures state-of-the-art formulas for PBM Products and its retail partners. Whether a store brand carries its own retail name or is part of a wholesaler's private-label program, store-brand products give retailers a way to make a higher margin, differentiate themselves from the competition, and win the loyalty of customers. It believes their extensive private-label product lines are helping some of the largest retailers in America accomplish their business goals. In turn, their retail partners are helping them to accomplish its mission. PBM partners with leading food and drug retailers to provide high-quality, competitively priced products to customers labeled under the store brands of companies such as Wal-Mart, Target, Kroger, Loblaws, and Walgreens. | Food: Meat/Fish/Dairy | Corporate Officer/Principal | |
Alzheimer’s Association
 Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is based in Chicago, IL and has subsidiaries in the United States. The Alzheimer's Association provides information and resources for Alzheimer's and other dementias. Alzheimer’s Association was founded in 1980. Joanne Pike has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Epilepsy Foundation
 Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AstraZeneca Pharmaceuticals AB
 AstraZeneca Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceuticals AB is a Swedish pharmaceutical company. The company is based in Södertälje, Sweden. The company's description could not be retrieved due to an error. | Pharmaceuticals: Major | Director/Board Member | |
Enterprise Mortgage Acceptance Co. LLC
 Enterprise Mortgage Acceptance Co. LLC Miscellaneous Commercial ServicesCommercial Services Enterprise Mortgage Acceptance Co. LLC provides capital and financing options for equipment financing and business loans. The private company is based in Westport, CT and has subsidiaries in the United States. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
PBM Pharmaceuticals, Inc.
 PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA. | Pharmaceuticals: Major | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Perelman School of Medicine | College/University | Doctorate Degree | |
| The University of Virginia School of Medicine | College/University | Corporate Officer/Principal | |
| The Indiana University School of Medicine | College/University | Doctorate Degree | |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
| University of Iowa Carver College of Medicine | College/University | Doctorate Degree | |
| Huntington Study Group | Director/Board Member | ||
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Octagon Finance LLC
 Octagon Finance LLC Financial ConglomeratesFinance Octagon Finance LLC provides financial services. The private company is based in Durham. | Financial Conglomerates | Corporate Officer/Principal | |
| Novartis Gene Therapies Switzerland GmbH | Director/Board Member | ||
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
Envigo Rms LLC
 Envigo Rms LLC Miscellaneous Commercial ServicesCommercial Services Envigo Rms, LLC engages in the provision of research models to pharmaceutical and biotechnology industries, government, academia, and other life science organizations. The company was founded in May 30, 2019 and is headquartered in Indianapolis,IN. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member | |
| BrightFocus Foundation, Inc. | Director/Board Member | ||
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Cellevolve Bio
 Cellevolve Bio Pharmaceuticals: MajorHealth Technology Cellevolve Bio is a company that specializes in the development and commercialization of cell therapies. The company is based in San Francisco, CA. The company's mission is to translate innovation into commercially available treatments to accelerate the revolution in cell therapy. Cellevolve understands that cell therapy innovations require unique and specialized capabilities to advance them to approval and beyond. The company was founded by leaders with extensive experience in developing and launching therapeutics. The company was founded by Derrell D. Porter, who has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Executive Officer | |
| National Association of Epilepsy Centers | President | ||
| Hexokine Therapeutics, Inc. | Chief Executive Officer | ||
| Baxis Pharmaceuticals, Inc. | Director/Board Member | ||
| Vetana Animal Health, Inc. | Director/Board Member | ||
| Seimers Integration LLC | President | ||
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 48 |
| Svezia | 2 |
| Svizzera | 2 |
Settori
| Health Technology | 19 |
| Consumer Services | 14 |
| Finance | 5 |
| Commercial Services | 5 |
| Consumer Non-Durables | 2 |
Posizioni
| Director/Board Member | 61 |
| Corporate Officer/Principal | 49 |
| Undergraduate Degree | 17 |
| Director of Finance/CFO | 16 |
| Independent Dir/Board Member | 16 |
Contatti più connessi
| Insiders | |
|---|---|
| Matthew Zuga | 32 |
| Sean Stalfort | 28 |
| Kimberlee Drapkin | 23 |
| Derrell Porter | 14 |
| Jeffrey Ives | 13 |
| Daniel O'Connell | 11 |
| Laura Stoppel | 9 |
| Eric Siemers | 8 |
| Derek Meisner | 8 |
| Nathan Fountain | 7 |
| Russell Barton | 6 |
| Jim Doherty | 6 |
| Steve Reynolds | 5 |
| Janice Hitchcock | 3 |
| Julie Bockenstette | 3 |
- Borsa valori
- Insiders
- Alexandria Braun
- Connessioni Società
